Citations

Mayo Clinic

Clear

4085 citation(s) found for "Yu, Jonathan".

Risk of Recurrent Ischemic Stroke in Patients With a Cardiac Thrombus
Nio, Shan Sui , Beemsterboer, Chiel F.P. , Goedman, Aletta F. , Planken, R. Nils , Coutinho, Jonathan M. , Rinkel, Leon A. , Beemsterboer, Chiel F P , Planken, R Nils , Coutinho, Jonathan M

Neurology Open Access | August 1, 2025 | Volume: 1 | Issue: 3 | Pages: No page available

10.1212/wn9.0000000000000030 Get It

A case of Alice in Wonderland Syndrome associated with topiramate in a patient with vestibular migraine
Jiang, Wen X. , Leung, Jonathan G. , Carlson, Danielle N. , Staab, Jeffrey P. , Leung, Jonathan G , Staab, Jeffrey P

Mental Health Clinician | August 1, 2025 | Volume: 15 | Issue: 4 | Pages: 208-13

10.9740/mhc.2025.08.208 | PMID 40933620 Get It

Abstract Introduction Alice in Wonderland Syndrome (AIWS) is an uncommon condition manifesting visual and somatosensory disturbances in which patients may perceive objects, including their own bodies, as larger or smaller than they are. In adults, AIWS typically is associated with migraine and epilepsy but has been reported as an adverse effect of topiramate, which is used to treat both illnesses, making it difficult to ascertain whether illness or medication causes altered perceptions. Reported is a case of topiramate-associated AIWS, which adds to the limited reports published on this unique phenomenon. Case Report A 40-year-old woman admitted to a 3-week pain rehabilitation program to treat chronic migraine reported macrosomatognosia that she retrospectively recalled beginning during titration of topiramate. The symptoms of AIWS resolved after the topiramate was discontinued. An assessment with the Naranjo ADR Probability Scale indicated a possible association between topiramate and macrosomatognosia. Discussion In this patient with migraine, the onset of AIWS coincided with titration of topiramate, providing a clue that its emergence may have been an adverse drug reaction rather than the underlying illness. Consistent with previous reports, AIWS resolved shortly after topiramate was discontinued, lending credence to this conclusion. However, the mechanism of AIWS is unknown and may be multifactorial, leaving the possibility that migraine predisposed the patient to develop AIWS from topiramate. Conclusion The long association of AIWS with migraine and epilepsy makes it possible that cases caused by medications used to treat these illnesses, like topiramate, are underreported. Awareness of the temporal relationships between the course of illness and the timing of drug therapy can help guide the recognition of AIWS as a potential adverse event.
Sudden cardiac death secondary to acute aortic syndromes in young athletes in the United States
Petek, Bradley J. , Moulson, Nathaniel , Kliethermes‌, Stephanie , Maleszewski, Joseph J. , Drezner, Jonathan A. , Churchill, Timothy W. , Drezner, Jonathan A , Churchill, Timothy W , Kliethermes, Stephanie A , Baggish, Aaron L. , Delong, Randi , Kucera, Kristen L. , Harmon, Kimberly G.

European Journal of Preventive Cardiology | July 30, 2025 | Volume: 33 | Issue: 8 | Pages: 1499-1501

10.1093/eurjpc/zwaf472 | PMID 40737489 Get It

Interobserver Reproducibility of Pelvicalyceal Invasion in Renal Cell Carcinoma Nephrectomies Among Genitourinary Pathologists
Sangoi, Ankur R. , Mubeen, Aysha , Humble, Robert , Wu, Douglas, Amin, Mahul, Aron, Manju , Brimo, Fadi , Chan, Emily , Cheng, Liang, Cheville, John C. , Collins, Katrina, Cornejo, Kristine M. , Downes, Michelle R. , Epstein, Jonathan I. , Hirsch, Michelle S. , Mohanty, Sambit K. , Netto, George J. , Osunkoya, Adeboye O. , Paner, Gladell P. , Rao, Priya, Smith, Steven C. , Tickoo, Satish K. , Tretiakova, Maria , Trpkov, Kiril , Wobker, Sara E. , Tamboli, Pheroze, Zynger, Debra L. , Cheng, Liang , Collins, Katrina , Cheng, Liang , Sangoi, Ankur R , Tretiakova, Maria S , Trpkov, Kiril , Akgül, Mahmut , Pacheco, Richard R. , Acosta, Andrés , Amin, Mahul, Dhillon, Jasreman , Kapur, Payal , Lobo, Anandi , Mehra, Rohit, Saleeb, Rola , Shah, Rajal B. , Shen, Steven S. , Tamboli, Pheroze, Williamson, Sean R.

American Journal of Surgical Pathology | July 30, 2025 | Volume: 49 | Issue: 12 | Pages: 1307-1314

10.1097/pas.0000000000002456 | PMID 40734292 Get It

Pelvicalyceal invasion (PCI) is a relatively novel pT3a staging parameter for renal cell carcinoma (RCC) nephrectomies. While interobserver reproducibility staging studies of sinus/vascular invasion in RCC exist, a similar evaluation for PCI has not been performed. Moreover, in our experience, there is also diagnostic variability in how pathologists interpret PCI. Herein, we explore interobserver reproducibility among genitourinary (GU) pathologists. Twenty hematoxylin and eosin-stained digitized slides from RCCs (all grossly approaching the renal pelvis) were distributed to 31 GU pathologists to classify each as PCI or not PCI based on their respective clinical practices; slides with concomitant sinus/fat/vascular invasion were excluded. Slides were then evaluated for the following 4 morphologic features: tumor abutting renal pelvis, tumor pushing/indenting into the renal pelvis, polypoid configuration of tumor into the renal pelvis, and tumor eroding through renal pelvic urothelium. Interobserver reproducibility was assessed, and the morphologic features were correlated with PCI. Relationships between pathologists’ interpretations, morphologic features, and PCI were evaluated using hierarchical clustering. Although the diagnosis of PCI was relatively uniform with a majority agreement (>67%) reached in 16/20 slides, overall interobserver reproducibility was only moderate (kappa=0.601). While all 4 morphologic features were sensitive for PCI, polypoid configuration of the tumor into the renal pelvis and the tumor eroding through the renal pelvic urothelium were most specific (90%, 100%, respectively). Although we show general consensus among genitourinary pathologists on PCI assessment, clarifying the diagnostic guidelines with specific criteria should be included in pathologic staging systems.
Disparities During Family-Centered Rounds for Families Using Languages Other Than English
Pelpola, Judith S., Rojas, Christina R. , Blakeney, Erin Abu‐Rish , Farkas, Jonathan S. , Everhart, Jennifer L., Fan, Angela L. , Johnson, Tyler , Kajiwara, Yuko, Knoebel, Erin, Lewis, Kheyandra D. , Mallick, Nandini, Markle, Peggy, Romano, Eileen M., Shaughnessy, Erin E. , Calaman, Sharon, Landrigan, Christopher P. , Khan, Alisa , Johnson, Tyler , García, Sonia , Graham, Dionne A. , Johnson, Tyler M., Romano, Eileen M., Baird, Jennifer D. , Spector, Nancy Dollase

Pediatrics | July 28, 2025 | Volume: 156 | Issue: 2 | Pages: No page available

10.1542/peds.2024-070285 | PMID 40716767 Get It

BACKGROUND/OBJECTIVE Patient- and family-centered rounds (PFCR) have become a pediatric standard of care. However, rounds experiences of families using languages other than English (LOE)—particularly languages other than English or Spanish (LOES; eg, Arabic)—receive less focus. We aimed to identify differences in PFCR communication and engagement by language. METHODS We analyzed postintervention data from a 21-center structured PFCR study, assessing communication practices, quality, and family and nurse engagement during PFCR. Logistic regression adjusted by site compared PFCR between families using (1) LOE vs English, (2) Spanish vs English, and (3) LOES vs English. RESULTS Among 3051 PFCR encounters, 348 (11.4%) involved LOE (Spanish = 260; LOES = 85). Interpretation was not used in 7.2%, 5.8%, and 9.4% of encounters using LOE, Spanish, and LOES, respectively. PFCR in the following groups had lower adjusted odds (adjusted odds ratio [95% CI]) for the following domains: (1) LOE vs English: including providing verbal patient summaries (0.66 [0.46–0.95]), explaining diagnoses and differentials (0.62 [0.44–0.88]), family engagement (0.34 [0.20–0.57]), nursing inclusion (0.75 [0.60–0.93]), and nursing engagement (0.69 [0.52–0.90]). (2) Spanish vs English: diagnoses/differentials being explained (0.56 [0.37–0.85]), family engagement (0.35 [0.18–0.67]), nursing inclusion (0.77 [0.59–1.00]), and nursing engagement (0.68 [0.52–0.89]). (3) LOES vs English: families sharing concerns (0.66 [0.47–0.93]), family engagement (0.30 [0.16–0.54]), and nursing inclusion (0.74 [0.55–0.99]). CONCLUSION Even after implementing a PFCR intervention, families using LOE—especially LOES—experienced significant disparities in communication and engagement. Future approaches to improving PFCR should emphasize language access and promote nurse and family engagement for families using LOE, particularly LOES.
A proposed clinical guide to delivering Lower Extremity Extracorporeal Distal Revascularization (LEEDR) as a bridge to definitive care in acute limb ischemia
Dvir, May , Jodłowski, Grzegorz , Stonko, David P. , Nelson, Jack, Morrison, Jonathan J. , Treffalls, Rebecca, Morrison, Jonathan J , Stonko, David P , Treffalls, Rebecca N. , Nelson, Jack, Walker, Patrick F.

Perfusion | July 25, 2025 | Volume: 41 | Issue: 3 | Pages: 254-259

10.1177/02676591251363374 | PMID 40708295 Get It

Introduction Lower Extremity Extracorporeal Distal Revascularization (LEEDR) is a novel, preclinically tested technique designed to provide temporary limb perfusion in cases of acute limb ischemia when immediate revascularization is not feasible. Methods LEEDR employs an extracorporeal pump and circuit to draw arterial blood from a proximal inflow site and deliver it to an outflow artery within the ischemic limb. The system is designed for bedside initiation using percutaneous access. Results ALI from embolism, thrombosis, or trauma rapidly leads to irreversible tissue damage. Delays in revascularization are associated with high rates of limb loss and systemic complications. LEEDR offers a time-sensitive intervention aimed at mitigating these risks and preserving limb viability until definitive treatment is available. Conclusion LEEDR is a promising temporary perfusion strategy for limb salvage in ALI. This manuscript outlines its procedural components, technical considerations, and anticipated role in bridging patients to definitive revascularization.
Comparative Effectiveness Research Using Randomized Trials and Observational Studies: Validity and Feasibility Considerations
Bikdeli, Behnood , Bukhari, Syed , You, Seng Chan , Wallach, Joshua D. , Lip, Gregory Y H , Wallach, Joshua D , Ross, Joseph S. , Jeffery, Molly Moore , Cohen, David Jonathan , Januzzi, James Louis

Thrombosis and Haemostasis | July 24, 2025 | Volume: 126 | Issue: 04 | Pages: 335-345

10.1055/a-2664-7887 | PMID 40719151 Get It

Abstract In comparative effectiveness research (CER), ensuring internal, construct, and external validity is crucial. Internal validity determines whether observed outcomes are causally linked to an intervention; construct validity assesses whether a study measures what it intends to; and external validity relates to generalizability in routine practice. Double-blind randomized trials optimize internal validity by minimizing bias and confounding, while construct validity is strengthened through pre-specified protocols and standardized data collection. However, controlled conditions limit external validity. Pragmatic RCTs improve generalizability but may compromise internal validity due to open-label designs. Observational CER studies—including observational studies following the target trial emulation framework—offer broader external validity and feasibility in less time and at lower cost. However, due to lack of random assignment, these studies are susceptible to measured and unmeasured confounding. Several techniques help mitigate these concerns, including a detailed pre-specified protocol, tools such as propensity score matching to balance measured confounders, falsification endpoint testing for assessing the presence of unmeasured confounders, and quasi-experimental designs (including instrumental variable analysis), which may be able to address both. Pre-specified sensitivity analyses and triangulation with complementary data sources further enhance robustness. Construct validity in observational CER depends on accurate patient profiling and validated computational phenotypes for identifying patients, exposures, and outcomes. Thoughtful study design and analytic rigor are essential for balancing these validity considerations. This brief review highlights these issues with examples from thrombosis research.
Adult Congenital Heart Disease as a Career? Examining Encouraging and Deterring Factors in the Global ACHD Survey
Bravo‐Jaimes, Katia , Srour, M. , Luna‐López, Raquel , Kandavello, Geetha , Guerrero‐Chalela, Carlos‐Eduardo , García‐Cruz, Edgar , Ackerman, Judith , Elizari, Amalia , Valdez‐Ramos, Miriam , Cupido, Blanche , Almasri, Murad , Phillips, Sabrina D. , Windram, Jonathan , Srour, M H D Osama, Jenkins, Petra , Luna-Lopez, Raquel , Kandavello, Geetha , Guerrero-Chalela, Carlos-Eduardo , García-Cruz, Edgar , Ackerman, Judith , Valdez-Ramos, Miriam , Cupido, Blanche , Zentner, Dominica , Phillips, Sabrina, McLeod, Christopher J , Burchill, Luke J , Kamath, Celia C , Bullock-Palmer, Renee P , Bravo-Jaimes, Katia , Srour, M. H. D. Osama, Tutarel, Oktay , McLeod, Christopher J. , Burchill, Luke J. , Kamath, Celia , Bullock-Palmer, Renée P.

Journal of the American Heart Association | July 21, 2025 | Volume: 14 | Issue: 15 | Pages: No page available

10.1161/jaha.125.041276 | PMID 40689513 Get It

Background There is a global mismatch between the number of adults with congenital heart disease and adult congenital heart disease (ACHD) cardiologists, potentially impacting patient outcomes. This survey explores factors influencing trainees and cardiologists' career choices in ACHD. Methods An online, anonymous global survey on demographics, ACHD as a career choice, encouraging and deterring factors assessed via a 5‐point Likert scale and open‐ended questions on recommending ACHD was distributed through targeted emails and social media. Responses meeting a 75% completion criterion were analyzed using descriptive statistics and thematic analysis. Results Among 811 included responses, most were from women (53.5%), aged 31 to 40 years (48.3%), White individuals (43.3%), non‐Hispanic individuals (85%), from outside the ACHD field (79.0%), and from North America (42.7%). Only 30.9% of non‐ACHD physicians considered specializing in ACHD despite 78.9% recommending it. Encouraging factors included awareness of ACHD significance, mentor influence, and clinical exposure. Key deterrents were inadequate financial incentives, limited job opportunities, and lengthy training. Regional variations showed that longer training duration and lack of compensation incentives were the main deterrents in North America. Suggested solutions included structured training programs, salary improvements, and early ACHD exposure during medical education. Conclusions Less than a third of respondents considered ACHD as a career largely due to inadequate financial incentives, limited job opportunities, and long training duration. Addressing these barriers could enhance recruitment and help meet the growing demands of the ACHD population.